All eyes on a phosphatase in glioma stem cells
Open Access
- 12 October 2021
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 218 (11)
- https://doi.org/10.1084/jem.20211605
Abstract
In this issue of JEM, Zhang et al. identify a dependency of glioma stem cells on tyrosine phosphatase activity of EYA2 and a new role for this phosphatase at the centrosome, offering a new therapeutic approach to target mitotic activity in glioblastoma.This publication has 16 references indexed in Scilit:
- Primary brain tumours in adultsThe Lancet, 2018
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaScience, 2014
- Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell MigrationOnline Journal of Public Health Informatics, 2014
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma PrecursorsCancer Cell, 2011
- Deadly Teamwork: Neural Cancer Stem Cells and the Tumor MicroenvironmentCell Stem Cell, 2011
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cellsNature, 2006
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisCancer Cell, 2006